30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Healthcare Equipment & Supplies

Accendra Health Inc (ACH)

Track

The most recent insider trading activity occurred on August 14, 2025, with Coliseum Capital Management, LLC executing a significant buy transaction. Prior to this, several other substantial buy transactions were also made by Coliseum Capital Management, LLC in August 2025 and April 2025. The last reported sale transactions were in November 2024.
Stock chart
Ticker: ACH Exchange: NYS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Coliseum Capital Management, LLC
1 purchase — total 2,617,044 USD
Buy 14 Aug 2025
Value US$3,902,746.14 | Price 309.71 | Shares 87,524
Buy 13 Aug 2025
Value US$2,563,406.21 | Price 483.91 | Shares 39,730
Buy 12 Aug 2025
Value US$3,708,000.00 | Price 5.15 | Shares 720,000
Buy 10 Apr 2025
Value US$575,200.00 | Price 7.19 | Shares 80,000
Buy 9 Apr 2025
Value US$1,662,750.00 | Price 7.39 | Shares 225,000
Buy 8 Apr 2025
Value US$835,800.00 | Price 7.96 | Shares 105,000
Buy 7 Apr 2025
Value US$1,881,600.00 | Price 7.84 | Shares 240,000
Buy 4 Apr 2025
Value US$1,044,817.84 | Price 8.14 | Shares 128,356
Buy 3 Apr 2025
Value US$1,364,800.00 | Price 8.53 | Shares 160,000
Buy 4 Mar 2025
Value US$7,800,000.00 | Price 9.75 | Shares 800,000
Buy 3 Mar 2025
Value US$3,261,540.19 | Price 9.19 | Shares 354,901
Buy 28 Feb 2025
Value US$16,324,618.29 | Price 9.39 | Shares 1,738,511
Planned sale 21 Nov 2024
Value US$62,433.24 | Price 11.82 | Shares 5,282
Proposed sale 21 Nov 2024
Value US$62,433.24 | Price 11.82 | Shares 5,282
Planned sale 18 Nov 2024
Value US$25,194.30 | Price 12.26 | Shares 2,055
Proposed sale 18 Nov 2024
Value US$25,194.30 | Price 12.26 | Shares 2,055
Proposed sale 20 Sep 2024
Value US$53,920.66 | Price 15.93 | Shares 3,384
Planned sale 22 Aug 2024
Value US$118,725.00 | Price 15.83 | Shares 7,500
Proposed sale 22 Aug 2024
Value US$118,725.00 | Price 15.83 | Shares 7,500
Proposed sale 16 Aug 2024
Value US$10,160.00 | Price 16.00 | Shares 635
Proposed sale 23 Jul 2024
Value US$389,259.98 | Price 16.79 | Shares 23,183
Planned sale 6 Jun 2024
Value US$49,526.22 | Price 17.48 | Shares 2,833
Planned sale 6 Jun 2024
Value US$79,420.05 | Price 17.49 | Shares 4,542
Planned sale 6 Jun 2024
Value US$188,136.42 | Price 17.49 | Shares 10,756
Planned sale 6 Jun 2024
Value US$32,919.89 | Price 17.47 | Shares 1,884
Proposed sale 6 Jun 2024
Value US$350,002.50 | Price 17.49 | Shares 20,015
Planned sale 5 Jun 2024
Value US$161,184.00 | Price 17.25 | Shares 9,344
Proposed sale 5 Jun 2024
Value US$161,184.00 | Price 17.25 | Shares 9,344
Planned sale 4 Jun 2024
Value US$172,853.60 | Price 17.32 | Shares 9,980
Proposed sale 4 Jun 2024
Value US$172,853.60 | Price 17.32 | Shares 9,980
Planned sale 3 Jun 2024
Value US$187,687.68 | Price 17.76 | Shares 10,568
Proposed sale 3 Jun 2024
Value US$187,687.68 | Price 17.76 | Shares 10,568
Planned sale 17 May 2024
Value US$39,111.12 | Price 19.06 | Shares 2,052
Proposed sale 17 May 2024
Value US$39,111.12 | Price 19.06 | Shares 2,052
Planned sale 16 May 2024
Value US$40,985.58 | Price 20.18 | Shares 2,031
Proposed sale 16 May 2024
Value US$40,985.58 | Price 20.18 | Shares 2,031
Planned sale 1 May 2024
Value US$490,258.14 | Price 24.27 | Shares 20,204
Planned sale 1 May 2024
Value US$95,421.70 | Price 24.53 | Shares 3,890
Proposed sale 1 May 2024
Value US$585,680.81 | Price 24.31 | Shares 24,094
Planned sale 22 Apr 2024
Value US$124,200.00 | Price 24.84 | Shares 5,000
Proposed sale 22 Apr 2024
Value US$124,200.00 | Price 24.84 | Shares 5,000
Planned sale 27 Feb 2024
Value US$250,000.00 | Price 25.00 | Shares 10,000
Proposed sale 27 Feb 2024
Value US$250,000.00 | Price 25.00 | Shares 10,000
Planned sale 20 Feb 2024
Value US$110,000.00 | Price 22.00 | Shares 5,000
Proposed sale 20 Feb 2024
Value US$110,000.00 | Price 22.00 | Shares 5,000
Planned sale 7 Feb 2024
Value US$1,931.27 | Price 19.91 | Shares 97
Proposed sale 7 Feb 2024
Value US$1,931.27 | Price 19.91 | Shares 97
Planned sale 17 Jan 2024
Value US$135,600.00 | Price 18.08 | Shares 7,500
Proposed sale 17 Jan 2024
Value US$135,600.00 | Price 18.08 | Shares 7,500
Planned sale 20 Dec 2023
Value US$106,700.00 | Price 21.34 | Shares 5,000
Proposed sale 20 Dec 2023
Value US$106,700.00 | Price 21.34 | Shares 5,000
Planned sale 22 Nov 2023
Value US$361,916.36 | Price 18.75 | Shares 19,302
Proposed sale 21 Nov 2023
Value US$367,896.12 | Price 19.06 | Shares 19,302
Planned sale 20 Nov 2023
Value US$93,100.00 | Price 18.62 | Shares 5,000
Proposed sale 20 Nov 2023
Value US$93,100.00 | Price 18.62 | Shares 5,000
Proposed sale 10 Nov 2023
Value US$96,635.00 | Price 17.57 | Shares 5,500
Planned sale 10 Nov 2023
Value US$96,635.00 | Price 17.57 | Shares 5,500
Proposed sale 10 Nov 2023
Value US$222,576.76 | Price 17.57 | Shares 12,668
Planned sale 10 Nov 2023
Value US$222,576.76 | Price 17.57 | Shares 12,668
Proposed sale 9 Aug 2023
Value US$981,302.51 | Price 20.37 | Shares 48,170
Planned sale 16 Jun 2023
Value US$105,161.49 | Price 19.28 | Shares 5,455
Planned sale 16 Jun 2023
Value US$529,798.21 | Price 19.27 | Shares 27,488
Planned sale 16 Jun 2023
Value US$112,526.85 | Price 19.28 | Shares 5,837
Proposed sale 16 Jun 2023
Value US$749,229.60 | Price 19.32 | Shares 38,780
Planned sale 15 Jun 2023
Value US$104,902.92 | Price 19.23 | Shares 5,455
Planned sale 15 Jun 2023
Value US$112,280.53 | Price 19.24 | Shares 5,837
Planned sale 15 Jun 2023
Value US$528,913.10 | Price 19.24 | Shares 27,488
Proposed sale 15 Jun 2023
Value US$728,676.20 | Price 18.79 | Shares 38,780
Planned sale 9 Jun 2023
Value US$2,472,941.26 | Price 20.79 | Shares 118,928
Proposed sale 9 Jun 2023
Value US$2,524,841.44 | Price 21.23 | Shares 118,928
Planned sale 8 Jun 2023
Value US$2,520,120.00 | Price 21.19 | Shares 118,928
Proposed sale 8 Jun 2023
Value US$2,559,330.56 | Price 21.52 | Shares 118,928
Planned sale 7 Jun 2023
Value US$2,564,553.72 | Price 21.56 | Shares 118,927
Proposed sale 7 Jun 2023
Value US$2,470,113.79 | Price 20.77 | Shares 118,927
Planned sale 6 Jun 2023
Value US$211,100.00 | Price 21.11 | Shares 10,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2025-08-14 2025-08-14 B Purchase
3.3
Coliseum Capital Management, LLC
Large shareholder
87,524 +17.8%
309.71
US$3,902,746 		87,524 +17.8% 309.71 US$3,902,746
2025-08-14 2025-08-13 B Purchase
3.3
Coliseum Capital Management, LLC
Large shareholder
39,730 +7.4%
483.91
US$2,563,406 		39,730 +7.4% 483.91 US$2,563,406
2025-08-14 2025-08-12 B Purchase
3.3
Coliseum Capital Management, LLC
Large shareholder
77,916 -20.2%
250.78
US$3,805,703 		77,916 -20.2% 250.78 US$3,805,703
2025-04-10 2025-04-10 B Purchase
3.3
Coliseum Capital Management, LLC
Large shareholder
80,000 +0.7%
7.19
US$575,200 		80,000 +0.7% 7.19 US$575,200
2025-04-10 2025-04-09 B Purchase
3.3
Coliseum Capital Management, LLC
Large shareholder
225,000 +2.0%
7.39
US$1,662,750 		225,000 +2.0% 7.39 US$1,662,750
2025-04-10 2025-04-08 B Purchase
3.3
Coliseum Capital Management, LLC
Large shareholder
105,000 +0.9%
7.96
US$835,800 		105,000 +0.9% 7.96 US$835,800
2025-04-07 2025-04-07 B Purchase
3.3
Coliseum Capital Management, LLC
Large shareholder
240,000 +2.2%
7.84
US$1,881,600 		240,000 +2.2% 7.84 US$1,881,600
2025-04-07 2025-04-04 B Purchase
3.3
Coliseum Capital Management, LLC
Large shareholder
128,356 +1.2%
8.14
US$1,044,818 		128,356 +1.2% 8.14 US$1,044,818
2025-04-07 2025-04-03 B Purchase
3.3
Coliseum Capital Management, LLC
Large shareholder
160,000 +1.5%
8.53
US$1,364,800 		160,000 +1.5% 8.53 US$1,364,800
2025-03-04 2025-03-04 B Purchase
3.3
Coliseum Capital Management, LLC
Large shareholder
800,000 +8.1%
9.75
US$7,800,000 		800,000 +8.1% 9.75 US$7,800,000
2025-03-04 2025-03-03 B Purchase
3.3
Coliseum Capital Management, LLC
Large shareholder
354,901 +3.7%
9.19
US$3,261,540 		354,901 +3.7% 9.19 US$3,261,540
2025-03-04 2025-02-28 B Purchase
3.3
Coliseum Capital Management, LLC
Large shareholder
1,738,511 +22.5%
9.39
US$16,324,618 		1,738,511 +22.5% 9.39 US$16,324,618
2024-11-25 2024-11-21 PlS Planned sale
0.7
Leon Jonathan A

EVP, Chief Financial Officer

Officer
5,282 -3.9%
11.82
US$62,433 		5,282 -3.9% 11.82 US$62,433
2024-11-21 2024-11-21 PrS Proposed sale
0.7
Leon Jonathan A

Officer

Officer
5,282
11.82
US$62,433 		5,282 11.82 US$62,433
2024-11-19 2024-11-18 PlS Planned sale
Sarkar Snehashish

Chief Information Officer
2,055 -3.5%
12.26
US$25,194 		2,055 -3.5% 12.26 US$25,194
2024-11-18 2024-11-18 PrS Proposed sale
Sarkar Snehashish

Officer

Officer
2,055
12.26
US$25,194 		2,055 12.26 US$25,194
2024-09-20 2024-09-20 PrS Proposed sale
Bruni Alexander J

Former Officer

Officer
3,384
15.93
US$53,921 		3,384 15.93 US$53,921
2024-08-26 2024-08-22 PlS Planned sale
0.7
Leon Jonathan A

SVP, Corp Treasurer, Intm CFO

Officer
7,500 -7.5%
15.83
US$118,725 		7,500 -7.5% 15.83 US$118,725
2024-08-22 2024-08-22 PrS Proposed sale
0.7
Leon Jonathan A

Officer

Officer
7,500
15.83
US$118,725 		7,500 15.83 US$118,725
2024-08-16 2024-08-16 PrS Proposed sale
Bruni Alexander J

Former Officer

Officer
635
16.00
US$10,160 		635 16.00 US$10,160
2024-07-23 2024-07-23 PrS Proposed sale
Starck Daniel J

Former Officer

Officer
23,183
16.79
US$389,260 		23,183 16.79 US$389,260
2024-06-07 2024-06-06 PlS Planned sale
Bernocchi Perry A

EVP, CEO,. Patient Direct

Officer
2,833 -2.1%
17.48
US$49,526 		2,833 -2.1% 17.48 US$49,526
2024-06-07 2024-06-06 PlS Planned sale
Bernocchi Perry A

EVP, CEO,. Patient Direct

Officer
4,542 -3.3%
17.49
US$79,420 		4,542 -3.3% 17.49 US$79,420
2024-06-07 2024-06-06 PlS Planned sale
Bernocchi Perry A

EVP, CEO,. Patient Direct

Officer
10,756 -7.3%
17.49
US$188,136 		10,756 -7.3% 17.49 US$188,136
2024-06-07 2024-06-06 PlS Planned sale
Bernocchi Perry A

EVP, CEO,. Patient Direct

Officer
1,884 -1.3%
17.47
US$32,920 		1,884 -1.3% 17.47 US$32,920
2024-06-06 2024-06-06 PrS Proposed sale
Bernocchi Perry A

Officer

Officer
20,015
17.49
US$350,002 		20,015 17.49 US$350,002
2024-06-06 2024-06-05 PlS Planned sale
Beck Mark A
Non-Executive Director
9,344 -45.6%
17.25
US$161,184 		9,344 -45.6% 17.25 US$161,184
2024-06-05 2024-06-05 PrS Proposed sale
Beck Mark A

Director

Non-Executive Director
9,344
17.25
US$161,184 		9,344 17.25 US$161,184
2024-06-05 2024-06-04 PlS Planned sale
Sarkar Snehashish

EVP, Chief Information Officer

Officer
9,980 -14.4%
17.32
US$172,854 		9,980 -14.4% 17.32 US$172,854
2024-06-04 2024-06-04 PrS Proposed sale
Sarkar Snehashish

Officer

Officer
9,980
17.32
US$172,854 		9,980 17.32 US$172,854
2024-06-04 2024-06-03 PlS Planned sale
Bruni Alexander J

EVP, CFO

Officer
10,568 -17.5%
17.76
US$187,688 		10,568 -17.5% 17.76 US$187,688
2024-06-03 2024-06-03 PrS Proposed sale
Bruni Alexander J

Officer

Officer
10,568
17.76
US$187,688 		10,568 17.76 US$187,688
2024-05-20 2024-05-17 PlS Planned sale
Galloway Heath H

EVP,General Counsel & CorpSecy

Officer
2,052 -3.6%
19.06
US$39,111 		2,052 -3.6% 19.06 US$39,111
2024-05-17 2024-05-17 PrS Proposed sale
Galloway Heath H

Officer

Officer
2,052
19.06
US$39,111 		2,052 19.06 US$39,111
2024-05-20 2024-05-16 PlS Planned sale
Galloway Heath H

EVP,General Counsel & CorpSecy

Officer
2,031 -3.4%
20.18
US$40,986 		2,031 -3.4% 20.18 US$40,986
2024-05-16 2024-05-16 PrS Proposed sale
Galloway Heath H

Officer

Officer
2,031
20.18
US$40,986 		2,031 20.18 US$40,986
2024-05-03 2024-05-01 PlS Planned sale
Bernocchi Perry A

EVP, CEO,. Patient Direct

Officer
20,204 -10.6%
24.27
US$490,258 		20,204 -10.6% 24.27 US$490,258
2024-05-03 2024-05-01 PlS Planned sale
Bernocchi Perry A

EVP, CEO,. Patient Direct

Officer
3,890 -2.0%
24.53
US$95,422 		3,890 -2.0% 24.53 US$95,422
2024-05-01 2024-05-01 PrS Proposed sale
Bernocchi Perry A

Officer

Officer
24,094
24.31
US$585,681 		24,094 24.31 US$585,681
2024-04-23 2024-04-22 PlS Planned sale
0.7
Leon Jonathan A

SVP, Corporate Treasurer

Officer
5,000 -5.6%
24.84
US$124,200 		5,000 -5.6% 24.84 US$124,200
2024-04-22 2024-04-22 PrS Proposed sale
0.7
Leon Jonathan A

Officer

Officer
5,000
24.84
US$124,200 		5,000 24.84 US$124,200
2024-02-28 2024-02-27 PlS Planned sale
0.5
Lowry Michael Wayne

SVP, Corporate Controller

Officer
10,000 -12.2%
25.00
US$250,000 		10,000 -12.2% 25.00 US$250,000
2024-02-27 2024-02-27 PrS Proposed sale
0.5
Lowry Michael Wayne

Officer

Officer
10,000
25.00
US$250,000 		10,000 25.00 US$250,000
2024-02-22 2024-02-20 PlS Planned sale
0.7
Leon Jonathan A

SVP, Corporate Treasurer

Officer
5,000 -6.2%
22.00
US$110,000 		5,000 -6.2% 22.00 US$110,000
2024-02-20 2024-02-20 PrS Proposed sale
0.7
Leon Jonathan A

Officer

Officer
5,000
22.00
US$110,000 		5,000 22.00 US$110,000
2024-02-08 2024-02-07 PlS Planned sale
Galloway Heath H

EVP,General Counsel & CorpSecy

Officer
97 -0.3%
19.91
US$1,931 		97 -0.3% 19.91 US$1,931
2024-02-07 2024-02-07 PrS Proposed sale
Galloway Heath H

Officer

Officer
97
19.91
US$1,931 		97 19.91 US$1,931
2024-01-18 2024-01-17 PlS Planned sale
0.7
Leon Jonathan A

SVP, Corporate Treasurer

Officer
7,500 -8.3%
18.08
US$135,600 		7,500 -8.3% 18.08 US$135,600
2024-01-17 2024-01-17 PrS Proposed sale
0.7
Leon Jonathan A

Officer

Officer
7,500
18.08
US$135,600 		7,500 18.08 US$135,600
2023-12-21 2023-12-20 PlS Planned sale
0.7
Leon Jonathan A

SVP, Corporate Treasurer

Officer
5,000 -5.1%
21.34
US$106,700 		5,000 -5.1% 21.34 US$106,700
2023-12-20 2023-12-20 PrS Proposed sale
0.7
Leon Jonathan A

Officer

Officer
5,000
21.34
US$106,700 		5,000 21.34 US$106,700
2023-11-22 2023-11-22 PlS Planned sale
Bernocchi Perry A

EVP, CEO,. Patient Direct

Officer
19,302 -10.5%
18.75
US$361,916 		19,302 -10.5% 18.75 US$361,916
2023-11-21 2023-11-21 PrS Proposed sale
Bernocchi Perry A

Officer

Officer
19,302
19.06
US$367,896 		19,302 19.06 US$367,896
2023-11-21 2023-11-20 PlS Planned sale
0.7
Leon Jonathan A

SVP, Corporate Treasurer

Officer
5,000 -4.8%
18.62
US$93,100 		5,000 -4.8% 18.62 US$93,100
2023-11-20 2023-11-20 PrS Proposed sale
0.7
Leon Jonathan A

Officer

Officer
5,000
18.62
US$93,100 		5,000 18.62 US$93,100
2023-11-13 2023-11-10 PrS Proposed sale
Galloway Heath H

Officer

Officer
5,500
17.57
US$96,635 		5,500 17.57 US$96,635
2023-11-13 2023-11-10 PrS Proposed sale
Bruni Alexander J

Officer

Officer
12,668
17.57
US$222,577 		12,668 17.57 US$222,577
2023-11-13 2023-11-10 PlS Planned sale
Galloway Heath H

EVP,General Counsel & CorpSecy

Officer
5,500 -13.1%
17.57
US$96,635 		5,500 -13.1% 17.57 US$96,635
2023-11-13 2023-11-10 PlS Planned sale
Bruni Alexander J

EVP, CFO

Officer
12,668 -23.4%
17.57
US$222,577 		12,668 -23.4% 17.57 US$222,577
2023-08-09 2023-08-09 PrS Proposed sale
Pace Nicholas J

Officer

Officer
48,170
20.37
US$981,303 		48,170 20.37 US$981,303
2023-06-20 2023-06-16 PlS Planned sale
Pesicka Edward A

President & CEO

Executive Director
5,455 -0.8%
19.28
US$105,161 		5,455 -0.8% 19.28 US$105,161
2023-06-20 2023-06-16 PlS Planned sale
Pesicka Edward A

President & CEO

Executive Director
27,488 -3.7%
19.27
US$529,798 		27,488 -3.7% 19.27 US$529,798
2023-06-20 2023-06-16 PlS Planned sale
Pesicka Edward A

President & CEO

Executive Director
5,837 -0.8%
19.28
US$112,527 		5,837 -0.8% 19.28 US$112,527
2023-06-16 2023-06-16 PrS Proposed sale
Pesicka Edward A

Officer; Director

Executive Director
38,780
19.32
US$749,230 		38,780 19.32 US$749,230
2023-06-20 2023-06-15 PlS Planned sale
Pesicka Edward A

President & CEO

Executive Director
5,455 -0.7%
19.23
US$104,903 		5,455 -0.7% 19.23 US$104,903
2023-06-20 2023-06-15 PlS Planned sale
Pesicka Edward A

President & CEO

Executive Director
5,837 -0.8%
19.24
US$112,281 		5,837 -0.8% 19.24 US$112,281
2023-06-20 2023-06-15 PlS Planned sale
Pesicka Edward A

President & CEO

Executive Director
27,488 -3.5%
19.24
US$528,913 		27,488 -3.5% 19.24 US$528,913
2023-06-15 2023-06-15 PrS Proposed sale
Pesicka Edward A

Officer; Director

Executive Director
38,780
18.79
US$728,676 		38,780 18.79 US$728,676
2023-06-12 2023-06-09 PlS Planned sale
Pesicka Edward A

President & CEO

Executive Director
118,928 -13.1%
20.79
US$2,472,941 		118,928 -13.1% 20.79 US$2,472,941
2023-06-09 2023-06-09 PrS Proposed sale
Pesicka Edward A

Officer; Director

Executive Director
118,928
21.23
US$2,524,841 		118,928 21.23 US$2,524,841
2023-06-12 2023-06-08 PlS Planned sale
Pesicka Edward A

President & CEO

Executive Director
118,928 -11.6%
21.19
US$2,520,120 		118,928 -11.6% 21.19 US$2,520,120
2023-06-08 2023-06-08 PrS Proposed sale
Pesicka Edward A

Officer; Director

Executive Director
118,928
21.52
US$2,559,331 		118,928 21.52 US$2,559,331
2023-06-08 2023-06-07 PlS Planned sale
Pesicka Edward A

President & CEO

Executive Director
118,927 -10.4%
21.56
US$2,564,554 		118,927 -10.4% 21.56 US$2,564,554
2023-06-07 2023-06-07 PrS Proposed sale
Pesicka Edward A

Officer; Director

Executive Director
118,927
20.77
US$2,470,114 		118,927 20.77 US$2,470,114
2023-06-08 2023-06-06 PlS Planned sale
0.5
Lowry Michael Wayne

SVP, Corporate Controller

Officer
10,000 -11.1%
21.11
US$211,100 		10,000 -11.1% 21.11 US$211,100
Explore more

More insider trading research around Accendra Health Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Healthcare Services companies with insider activity
More Healthcare Equipment & Supplies companies with insider activity
Insider trading in North America